Literature DB >> 11308322

Screening of intestinal microflora for effective probiotic bacteria.

D J O'Sullivan1.   

Abstract

Increasing consumer awareness of health-promoting intestinal bacteria has fueled the addition of viable probiotic bacteria as functional ingredients in certain foods. However, to effectively market the enhanced attributes of these foods, the added probiotic bacteria need to have scientific credibility. The scientific rationale for using many of the strains of probiotic bacteria currently on the market is weak. Furthering the current understanding of what features a bacterium needs to have for effective probiotic functionality will enable the selection of strains with a more credible scientific rationale. To screen for effective strains, one must understand the microbial diversity in the intestines of healthy individuals. The advent of molecular tools has greatly enhanced our ability to accomplish this. These tools comprise genetic fingerprinting, specific probes, molecular speciation, and techniques for the in situ analysis of specific microbial groups in the intestine. This review will detail these scientific approaches and how their impact will improve criteria for selection of probiotic bacteria.

Mesh:

Year:  2001        PMID: 11308322     DOI: 10.1021/jf0012244

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  17 in total

1.  Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria.

Authors:  Amrita Palaria; Ivy Johnson-Kanda; Daniel J O'Sullivan
Journal:  Appl Environ Microbiol       Date:  2011-11-18       Impact factor: 4.792

2.  Sequence analysis of two cryptic plasmids from Bifidobacterium longum DJO10A and construction of a shuttle cloning vector.

Authors:  Ju-Hoon Lee; Daniel J O'Sullivan
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

3.  Cytoprotective agent in Lactobacillus bulgaricus extracts.

Authors:  Paul Johns; Suzette L Pereira; Amanda E Leonard; Pradip Mukerji; Robert A Shalwitz; Lobat Dowlati; Rosalyn R Phillips; Marti S Bergana; Jason D Holton; Tapas Das
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

4.  Transcription analysis of a lantibiotic gene cluster from Bifidobacterium longum DJO10A.

Authors:  Ju-Hoon Lee; Xiulan Li; Daniel J O'Sullivan
Journal:  Appl Environ Microbiol       Date:  2011-07-08       Impact factor: 4.792

Review 5.  Genomic insights into bifidobacteria.

Authors:  Ju-Hoon Lee; Daniel J O'Sullivan
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

6.  Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula.

Authors:  Monique Haarman; Jan Knol
Journal:  Appl Environ Microbiol       Date:  2005-05       Impact factor: 4.792

7.  Identification of iron-regulated genes of Bifidobacterium breve UCC2003 as a basis for controlled gene expression.

Authors:  Michelle Cronin; Aldert Zomer; Gerald F Fitzgerald; Douwe van Sinderen
Journal:  Bioeng Bugs       Date:  2012-05-01

8.  Mixed-species genomic microarray analysis of fecal samples reveals differential transcriptional responses of bifidobacteria in breast- and formula-fed infants.

Authors:  Eline S Klaassens; Rolf J Boesten; Monique Haarman; Jan Knol; Frank H Schuren; Elaine E Vaughan; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2009-03-13       Impact factor: 4.792

9.  Development of a Lactobacillus specific T-RFLP method to determine lactobacilli diversity in complex samples.

Authors:  Long Chen; Matt T Teasdale; Melissa M Kaczmarczyk; Gregory G Freund; Michael J Miller
Journal:  J Microbiol Methods       Date:  2012-08-17       Impact factor: 2.363

10.  Metatranscriptomic approach to analyze the functional human gut microbiota.

Authors:  María José Gosalbes; Ana Durbán; Miguel Pignatelli; Juan José Abellan; Nuria Jiménez-Hernández; Ana Elena Pérez-Cobas; Amparo Latorre; Andrés Moya
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.